Institute for Biomedicine

Deutsch

English
Italiano

Our starting point is always the individual and their unique characteristics, then comes the laboratory and finally we go back to people: this is how our research work is undertaken. We study how genetic heritage, the environments in which we live and our lifestyles affect the appearance and development of diseases as well as how these factors influence our health.

1 - 7

Institute for Biomedicine - Biomedicine Lab© Eurac Research - Ivo Corra'

Facts
& Figures

Staff members

39 with a PhD degree

Ongoing projects

28 of them with international partners

Journal publications

Contributions in conference proceedings

Laboratories and facilities

Biomedicine laboratory, Biobank, CHRIS Center

Data refer to the last issue of the Activity Report. See all Facts & Figures.

Research Field

1 - 3

Molecular and Cellular Biology

“Without understanding molecules we can only have a very sketchy understanding of life itself.” F. Crick

Health Data Science

"It is easy to lie with statistics. It is hard to tell the truth without it" A. Dunkels

ELSI

"Responsible research only happens if science and ethical analysis grow together"

News & Events

1 - 10

26 May 2023

Our Research at the Human Microbiome Symposium

22 May 2023

La diffusione dell'informazione dalla Ricerca alla pratica medica, alle persone

Due eventi locali organizzati in occasione della giornata mondiale dell’ipertensione.

05 May 2023

Ricerca sanitaria: sinergie tra Provincia, Asdaa ed Eurac Research

Azienda Sanitaria, Eurac Research e Amministrazione provinciale promuovono la ricerca sanitaria in Alto Adige.

02 May 2023

Kidney biomarkers and cardiovascular risk in South Tyrol population-based studies

We recently published a paper on PLOS ONE journal investigating how we can integrate routinely measured kidney biomarkers to predict cardiovascular risk over 10 years.

19 April 2023

New publication on mitochondrial dysfunction and Parkinson's disease

We identified potential presymptomatic molecular markers in clinically non-manifesting heterozygous PRKN variant carriers that could be used to monitor heterozygous PRKN variant carriers during the ...

31 March 2023

CHRIS COVID-19 study

A longitudinal analysis of a population representative sample

28 March 2023

Our new paper on Parkinson’s disease

We evaluated the neuroprotective role of a novel target against alpha-synuclein neuropathology and elucidated its role in the autophagy-lysosome pathway. We validated the potential of the small GTPase ...

23 March 2023

Presentazione ufficiale della nostra nuova sede al NOI Techpark

Siamo operativi nel nuovo laboratorio di circa 900 metri quadrati dove ogni giorno portiamo avanti la nostra Ricerca con l’obiettivo di migliorare le conoscenze sulla salute e sulle malattie.